Data Provider: Data is provided by Zacks Investment Research Data Provider: Data is provided by Zacks Investment Research BLOOMBERG NEWS/FILE 2007 Alnylam’s John Maraganore described the Genzyme deal as “transformational... BLOOMBERG NEWS/FILE 2007 Alnylam’s John Maraganore described the Genzyme deal as “transformational... Data Provider: Data is provided by Zacks Investment Research Data Provider: Data is provided by Zacks Investment Research GETTY Britain has received another Brexit boost The US firm is set to hire a new team of more than... GETTY Britain has received another Brexit boost The US firm is set to hire a new team of more than... 12.01.2014 New Paper Documenting Alnylam’s Pioneering Discovery of GalNAc-Conjugated siRNA We have... 12.01.2014 New Paper Documenting Alnylam’s Pioneering Discovery of GalNAc-Conjugated siRNA We have... Professional investors like Mignone spend considerable time and money conducting due diligence on... Professional investors like Mignone spend considerable time and money conducting due diligence on... Drugmaker Photos Shares Swiss Switzerland Philadelphia Daily News Roche launches $86.50-a-share bid... Drugmaker Photos Shares Swiss Switzerland Philadelphia Daily News Roche launches $86.50-a-share bid... Latest ALNY News Press Releases Better Buy: bluebird bio Inc. vs. Alnylam Pharmaceuticals Feb 28... Latest ALNY News | Press Releases Better Buy: bluebird bio, Inc. vs. Alnylam Pharmaceuticals Feb 28... Shutterstock Shutterstock UMASS MEDICAL SCHOOL (left); RUBY ARGUILLA TULL/BLOOMBERG NEWS (right) From left: Phillip D. Zamore... UMASS MEDICAL SCHOOL (left); RUBY ARGUILLA TULL/BLOOMBERG NEWS (right) From left: Phillip D. Zamore... 07.22.2014 RNAi Roundtable: Advances in Delivery of RNAi Therapeutics with Enhanced Stabilization... 07.22.2014 RNAi Roundtable: Advances in Delivery of RNAi Therapeutics with Enhanced Stabilization... Marc-Antoine Lucchini director general de Sanofi en España. La compañía farmacéutica francesa... Marc-Antoine Lucchini, director general de Sanofi en España. La compañía farmacéutica francesa... Alnylam Pharmaceuticals Inc. soared 52.2% making it the best performing stock on the S&P 500 after... Alnylam Pharmaceuticals Inc. soared 52.2% making it the best performing stock on the S&P 500, after... 360 Media Ventures Acadian ACE Accenture Acton Real Estate Adopt a Soldier Platoon Alnylam ... 360 Media Ventures Acadian ACE Accenture Acton Real Estate Adopt a Soldier Platoon Alnylam ... Web Page: www.Alnylam.com Back to Asymmetric Synthesis: A Symposium in Honor of Ernest Eliel... Web Page: www.Alnylam.com Back to Asymmetric Synthesis: A Symposium in Honor of Ernest Eliel... George Scangos PhD CEO Biogen Idec George Scangos, PhD CEO, Biogen Idec – Compania Monsanto are un nou partener şi anume Alnylam Pharmaceuticals Inc. o companie... – Compania Monsanto are un nou partener, şi anume Alnylam Pharmaceuticals Inc., o companie... Într-un cuvânt Alnylam este specializată în tehnologia cunoscută ca interferenţă ARN (ARNi) care... Într-un cuvânt, Alnylam este specializată în tehnologia cunoscută ca interferenţă ARN (ARNi) care...
Advanced Search